Emergency Cardiovascular Researcher, Emergency Physician, Entrepeneur, Professor
Joined December 2016
- Tweets242
- Following46
- Followers169
- Likes470
Simon A. Mahler retweeted
Proud of our STOP CP team’s new pub in @JAMACardio part of @JAMANetwork! ESC 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Coronary Artery Disease ja.ma/3yeW5G5
Simon A. Mahler retweeted
Impressive data, validation, and generalization. This is the future of ACS evaluation! Proud to be a part of ARTEMIS
Simon A. Mahler retweeted
Congratulations @johannesneuman @RTwerenbold on the late-breaking science ARTEMIS study presentation at #ESCCongress evaluating personalized diagnostic algorithms using machine learning for patients with suspected acute MI in a large international cohort involving 6 cTn assays.
Simon A. Mahler retweeted
Now in the latest @CircAHA issue, our primer endorsed by the IFCC C-CB addressing "High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain" bit.ly/3SUGwwh @CcbIfcc
Simon A. Mahler retweeted
#ICYMI: Appraisal of the 2021 Chest Pain Guidelines @mrapple004 @MahlerHEARTpath @yadersandoval #AHAJournals
#Primer HS Cardiac Troponin & Guidelines for Evaluation and Diagnosis of Acute Check Pain #AHAJournals ahajrnls.org/3PmL643
Simon A. Mahler retweeted
Check out the our EIC's Pick of the Month
FREE/OPEN ACCESS LINK: onlinelibrary.wiley.com/doi/…
Simon A. Mahler retweeted
#RCM - Vol. 22 No.4 (28/62)
🔔Review
#ScoringSystems for the triage and assessment of short-term #CardiovascularRisk in patients with #AcuteChestPain
@MahlerHEARTpath
Full-text:
imrpress.com/journal/RCM/22/…
Simon A. Mahler retweeted
Common comorbid conditions broadly influence the diagnostic performance of troponin, important real-world clinical implications 👉 Check out our #ESCAbstract on the #ESCCongress cyim.page.link/nYnN via @escardio @MahlerHEARTpath @bra07md
Simon A. Mahler retweeted
We are honored to announce today the formation of our Scientific Advisory Board.
The group is comprised of world-class experts, researchers and thought leaders spanning cardiology, emergency medicine and radiology.
Read our full press release here: lnkd.in/dJQKmARV
Simon A. Mahler retweeted
Impact of hs #troponin T implementation: results of our @MayoClinicHS study addressing transition from 4th to 5th Gen cTnT are now available in latest @JACCJournals issue bit.ly/3cZzNOC @iam_olatunde • Podcast bit.ly/2TPYpCv • Editorial bit.ly/2SJXgfN
Simon A. Mahler retweeted
Great to see continued endorsement of HEART score risk assessment for #EmergencyDepartment patients w/ chest pain - a core component of @medic_qi #qualityimprovement work to increase safe discharge rate for low risk patients
youtube.com/watch?v=zrjbPOuf…
@ABEMCert @MahlerHEARTpath
Simon A. Mahler retweeted
Congrats to third year resident @Nick_Ashburn1 for his award winning research presentation at the James E. Byrum Academic Forum titled “Prehospital time for patients with acute chest pain; a rural health disparity”
annemergmed.com/article/S019…
Congratulations to @richardbody on a well done meta-analysis evaluating the performance of EDACS.
Simon A. Mahler retweeted
Ground-breaking research, honestly just really glad to be a part of this amazing team! @mdcalc @mohammad @smuramed @RockyJedickMD @tahmadMD @jasoncsho @mpanhwar92 @DrRossMasood @HassanMashbari @SetarehMD
Simon A. Mahler retweeted
Always always
Any troponin worse than no troponin. More troponin worse than less troponin.
It aint that hard to understand relationship between troponin and prognosis.
Congratulations to @RTwerenbold well deserved!
Today, I am leaving the @UniSpitalBasel to follow my appointment to a professorship @UKEHamburg. Most grateful for every precious encounter, every lesson learnt and every common success with this great team @CRIBasel. The story is about to continue...
Simon A. Mahler retweeted
High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial | Circulation (1/6) #cardioed #foamed ahajournals.org/doi/10.1161/…
Really important study and editorial that challenge our assumptions about troponin measurement in the setting of myocardial ischemia.
Rapid troponin release after transient ischemia with coronary balloon inflation - cellular mechanisms, assay considerations and implications for practice #FOAMed @ChrisDefilippi @HighSTEACS @CircAHA
ahajournals.org/doi/10.1161/…
Simon A. Mahler retweeted
What does this mean for risk scores? HEART & EDACS included risk factors based on expert opinion, although they weren't predictive in the EDACS cohort either.
Maybe demographics & practices are changing, & maybe other prediction models could be refined & improved as a result